Clinical Trials Search Results

Results 31-40 of 41 for your search
Show Search Criteria
Atezolizumab and PGV001 in Treating Patients with Locally Advanced or Metastatic Urothelial Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: Icahn School of Medicine at Mount Sinai, New York, New York
Nivolumab in Treating Patients with Stage II-IV Muscle-Invasive Bladder, Urethra, or Ureter Cancer That Have Undergone Chemoradiotherapy
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: Huntsman Cancer Institute / University of Utah, Salt Lake City, Utah
Durvalumab and Tremelimumab in Treating Patients with Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated with Cisplatin-Based Therapy before Surgery
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: M D Anderson Cancer Center, Houston, Texas
Trial of CRLX101, a Nanoparticle Camptothecin With Olaparib in People With Relapsed / Refractory Small Cell Lung Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: University of Iowa / Holden Comprehensive Cancer Center, Iowa City, Iowa
Padeliporfin Phototherapy in Treating Patients with Recurrent Ureter and / or Renal Pelvis Urothelial Cancer
Status: Enrolling by Invitation
Age: 18 years and over
Gender: Male or Female
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Status: Temporarily Closed to Accrual
Age: 18 years and over
Gender: Male or Female
Location: 7 locations